Lv5
830 积分 2025-04-23 加入
Redox rhythms promote fitness by modulating ageing-dependent reprogramming
14天前
已完结
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
2个月前
已完结
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
3个月前
已完结
Cellular neighborhoods in cancer
4个月前
已完结
HER2 and urothelial carcinoma: current understanding and future directions
5个月前
已完结
Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody–drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study
5个月前
已完结
Tumour heterogeneity and resistance to cancer therapies
6个月前
已完结
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity
6个月前
已完结
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase 3 trial
7个月前
已完结
Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics
7个月前
已完结
皖公网安备34019202002308
